2-Cys peroxiredoxin function in intracellular signal transduction: Therapeutic implications

Trends in Molecular Medicine

Volumn 11, Issue 12, 2005, Pages 571-578

  Kang, Sang Won ^a   Rhee, Sue Goo ^a   Chang, Tong Shin ^a   Jeong, Woojin ^a   Choi, Min Hee ^a  

^a Ewha Womans University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HYDROGEN PEROXIDE; PEROXIREDOXIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOREDOXIN; THIOREDOXIN REDUCTASE;

CANCER; CATALYSIS; CEREBROVASCULAR DISEASE; MAMMAL; OXIDATIVE STRESS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REDUCTION; REVIEW; SIGNAL TRANSDUCTION; STIMULATION;

AMINO ACID SEQUENCE; HUMANS; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PEROXIDASES; REACTIVE OXYGEN SPECIES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 28244495868     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2005.10.006     Document Type: Review

References (78)

1. Y.S. Bae Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation J. Biol. Chem. 272 1997 217 221
2. 2 for platelet-derived growth factor signal transduction Science 270 1995 296 299
3. T. Finkel Oxygen radicals and signaling Curr. Opin. Cell Biol. 10 1998 248 253
4. S.G. Rhee Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation Sci. STKE 2000 2000 PE1
5. C.D. Putnam Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism J. Mol. Biol. 296 2000 295 309
6. R. Brigelius-Flohe Tissue-specific functions of individual glutathione peroxidases Free Radic. Biol. Med. 27 1999 951 965
7. J.B. de Haan Mice with a homozygous null mutation for the most abundant glutathione peroxidase, Gpx1, show increased susceptibility to the oxidative stress-inducing agents paraquat and hydrogen peroxide J. Biol. Chem. 273 1998 22528 22536
8. J.B. de Haan Fibroblasts derived from Gpx1 knockout mice display senescent-like features and are susceptible to H2O2-mediated cell death Free Radic. Biol. Med. 36 2004 53 64
9. S.G. Rhee Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling Free Radic. Biol. Med. 38 2005 1543 1552
10. Z.A. Wood Structure, mechanism and regulation of peroxiredoxins Trends Biochem. Sci. 28 2003 32 40
11. H.Z. Chae Characterization of three isoforms of mammalian peroxiredoxin that reduce peroxides in the presence of thioredoxin Diabetes Res. Clin. Pract. 45 1999 101 112
12. J.D. Lambeth NOX enzymes and the biology of reactive oxygen Nat. Rev. Immunol. 4 2004 181 189
13. Y.S. Bae Platelet-derived growth factor-induced H(2)O(2) production requires the activation of phosphatidylinositol 3-kinase J. Biol. Chem. 275 2000 10527 10531
14. H.S. Park Sequential activation of phosphatidylinositol 3-kinase, beta Pix, Rac1, and Nox1 in growth factor-induced production of H2O2 Mol. Cell. Biol. 24 2004 4384 4394
15. H.S. Park Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B J. Immunol. 173 2004 3589 3593
16. S.W. Kang Mammalian peroxiredoxin isoforms can reduce hydrogen peroxide generated in response to growth factors and tumor necrosis factor-alpha J. Biol. Chem. 273 1998 6297 6302
17. Jung, E.M. et al. Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated up-regulation of death receptor 5 (DR5). Carcinogenesis 26, 1905-1913
18. H. Kim Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells J. Biol. Chem. 275 2000 18266 18270
19. M.S. Seo Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate J. Biol. Chem. 275 2000 20346 20354
20. C.M. Wong Characterization of human and mouse peroxiredoxin IV: evidence for inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species Antioxid. Redox Signal. 2 2000 507 518
21. S.W. Kang Cytosolic peroxiredoxin attenuates the activation of Jnk and p38 but potentiates that of Erk in Hela cells stimulated with tumor necrosis factor-alpha J. Biol. Chem. 279 2004 2535 2543
22. 2. Role in cell survival following oxidant injury J. Biol. Chem. 271 1996 4138 4142
23. M.H. Choi Regulation of PDGF signalling and vascular remodelling by peroxiredoxin II Nature 435 2005 347 353
24. H. Aebi Catalase in vitro Methods Enzymol. 105 1984 121 126
25. L. Flohe, and W.A. Gunzler Assays of glutathione peroxidase Methods Enzymol. 105 1984 114 121
26. A. Mitsumoto Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat Free Radic. Res. 35 2001 301 310
27. T. Rabilloud Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site J. Biol. Chem. 277 2002 19396 19401
28. E. Wagner A method for detection of overoxidation of cysteines: peroxiredoxins are oxidized in vivo at the active-site cysteine during oxidative stress Biochem. J. 366 2002 777 785
29. K.S. Yang Inactivation of human peroxiredoxin I during catalysis as the result of the oxidation of the catalytic site cysteine to cysteine-sulfinic acid J. Biol. Chem. 277 2002 38029 38036
30. H.A. Woo Reversing the inactivation of peroxiredoxins caused by cysteine sulfinic acid formation Science 300 2003 653 656
31. B. Biteau ATP-dependent reduction of cysteine-sulphinic acid by S. cerevisiae sulphiredoxin Nature 425 2003 980 984
32. A.V. Budanov Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD Science 304 2004 596 600
33. H.H. Jang Two enzymes in one; two yeast peroxiredoxins display oxidative stress-dependent switching from a peroxidase to a molecular chaperone function Cell 117 2004 625 635
34. 2-induced cell death J. Biol. Chem. 280 2005 28775 28784
35. T.S. Chang Characterization of mammalian sulfiredoxin and its reactivation of hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in the active site to cysteine J. Biol. Chem. 279 2004 50994 51001
36. Z.A. Wood Peroxiredoxin evolution and the regulation of hydrogen peroxide signaling Science 300 2003 650 653
37. L. Cesaratto Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver Free Radic. Res. 39 2005 255 268
38. K.K. Griendling, and G.A. FitzGerald Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS Circulation 108 2003 1912 1916
39. C. Napoli Multiple role of reactive oxygen species in the arterial wall J. Cell. Biochem. 82 2001 674 682
40. P.A. Cerutti Oxy-radicals and cancer Lancet 344 1994 862 863
41. J.K. Andersen Oxidative stress in neurodegeneration: cause or consequence? Nat. Med. 10 Suppl 2004 S18 S25
42. J.W. Chang Augmented expression of peroxiredoxin I in lung cancer Biochem. Biophys. Res. Commun. 289 2001 507 512
43. P. Karihtala Peroxiredoxins in breast carcinoma Clin. Cancer Res. 9 2003 3418 3424
44. V.L. Kinnula Antioxidant enzymes and redox regulating thiol proteins in malignancies of human lung FEBS Lett. 569 2004 1 6
45. D.Y. Noh Overexpression of peroxiredoxin in human breast cancer Anticancer Res. 21 2001 2085 2090
46. Y. Qi Comparative proteomic analysis of esophageal squamous cell carcinoma Proteomics 5 2005 2960 2971
47. J. Shen Protein expression profiles in pancreatic adenocarcinoma compared with normal pancreatic tissue and tissue affected by pancreatitis as detected by two-dimensional gel electrophoresis and mass spectrometry Cancer Res. 64 2004 9018 9026
48. T. Yanagawa Peroxiredoxin I expression in human thyroid tumors Cancer Lett. 145 1999 127 132
49. T. Yanagawa Peroxiredoxin I expression in oral cancer: a potential new tumor marker Cancer Lett. 156 2000 27 35
50. K. Iwao-Koizumi Prediction of docetaxel response in human breast cancer by gene expression profiling J. Clin. Oncol. 23 2005 422 431
51. A.A. Memon Identification of differentially expressed proteins during human urinary bladder cancer progression Cancer Detect. Prev. 29 2005 249 255
52. J.H. Choi Overexpression of mitochondrial thioredoxin reductase and peroxiredoxin III in hepatocellular carcinomas Anticancer Res. 22 2002 3331 3335
53. J.S. Jang The differential proteome profile of stomach cancer: identification of the biomarker candidates Oncol. Res. 14 2004 491 499
54. J. Zuber A genome-wide survey of RAS transformation targets Nat. Genet. 24 2000 144 152
55. T.A. Sarafian Differential expression of peroxiredoxin subtypes in human brain cell types J. Neurosci. Res. 56 1999 206 212
56. K. Krapfenbauer Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt-Jacob disease Electrophoresis 23 2002 2541 2547
57. K. Krapfenbauer Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders Brain Res. 967 2003 152 160
58. F. Hattori Mitochondrial peroxiredoxin-3 protects hippocampal neurons from excitotoxic injury in vivo J. Neurochem. 86 2003 860 868
59. T. Ishii Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages J. Biol. Chem. 275 2000 16023 16029
60. T. Ishii Role of Nrf2 in the regulation of CD36 and stress protein expression in murine macrophages: activation by oxidatively modified LDL and 4-hydroxynonenal Circ. Res. 94 2004 609 616
61. A. Bast Oxidative and nitrosative stress induces peroxiredoxins in pancreatic beta cells Diabetologia 45 2002 867 876
62. J.H. Chen Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional gel electrophoresis and mass spectrometry Proc. Natl. Acad. Sci. U. S. A. 101 2004 17039 17044
63. A. Hess Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway J. Biol. Chem. 278 2003 45419 45434
64. S.T. Wen, and R.A. Van Etten The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity Genes Dev. 11 1997 2456 2467
65. Z.M. Mu Pag, a putative tumor suppressor, interacts with the Myc Box II domain of c-Myc and selectively alters its biological function and target gene expression J. Biol. Chem. 277 2002 43175 43184
66. C.A. Neumann Essential role for the peroxiredoxin Prdx1 in erythrocyte antioxidant defence and tumour suppression Nature 424 2003 561 565
67. D. Hanahan, and R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
68. S.H. Park Antisense of human peroxiredoxin II enhances radiation-induced cell death Clin. Cancer Res. 6 2000 4915 4920
69. T.S. Chang Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria J. Biol. Chem. 279 2004 41975 41984
70. D.R. Wonsey The c-Myc target gene PRDX3 is required for mitochondrial homeostasis and neoplastic transformation Proc. Natl. Acad. Sci. U. S. A. 99 2002 6649 6654
71. H. Shau Cloning and sequence analysis of candidate human natural killer-enhancing factor genes Immunogenetics 40 1994 129 134
72. R. Geiben-Lynn HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family J. Biol. Chem. 278 2003 1569 1574
73. C.K. Glass, and J.L. Witztum Atherosclerosis. the road ahead Cell 104 2001 503 516
74. F. Plaisant Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice Free Radic. Biol. Med. 34 2003 862 872
75. T.S. Chang Regulation of peroxiredoxin I activity by Cdc2-mediated phosphorylation J. Biol. Chem. 277 2002 25370 25376
76. S. Hirotsu Crystal structure of a multifunctional 2-Cys peroxiredoxin heme-binding protein 23 kDa/proliferation-associated gene product Proc. Natl. Acad. Sci. U. S. A. 96 1999 12333 12338
77. E. Schroder Crystal structure of decameric 2-Cys peroxiredoxin from human erythrocytes at 1.7 A resolution Structure Fold. Des. 8 2000 605 615
78. J.P. Declercq Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 A resolution J. Mol. Biol. 311 2001 751 759